Targeted therapy - state-of-the-art treatment option for advanced non-hodgkin lymphomas
Introduction: Non-Hodgkin lymphomas (NHL) are the most common hematologic malignancies within the structure of morbidity by malignant tumors, exhibiting in generalized stages a recurrent evolution and unfavorable prognosis, with negative socio-economic effects. Predominantly late diagnosis, increas...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2020-09-01
|
Series: | Hematology Reports |
Online Access: | https://www.pagepress.org/journals/index.php/hr/article/view/8923 |